ACUTE BACTERIAL MENINGITIS IN CHILDREN:
ISSUES IN DEVELOPING COUNTRIES
By Dr Simon KAYEMBA -KAYS, MBBS, MD
Profile of Lecturer
Download Powerpoint version of this lecture
A REVIEW OF GLOBAL QUESTIONS AND ANSWERS By Susan Bath, RGN RMN ICU, Meningitis Trust Helpline Services Manager
Profile
Download Word Document
To view each slide in full, please click in the corresponding slide thumbnail.
| Acute bacterial meningitis remains a major and serious
public health problem in both children and adults worldwide. The first half of the
twentieth century saw the development of the antibiotics; this was followed by the
development of third generation cephalosporins, which today constitute the corner stone of
modern treatment. Mortality and morbidity are however still significant despite the
development of modern and sophisticated diagnostic tests and adapted treatments (1
3). About 12% children die each year of meningitis and many others develop various
sequelae. In developed countries the diagnosis of
bacterial meningitis benefits from several tools; for example the measurement of serum or
cerebrospinal fluid (CSF) C Reactive Protein, CSF lactates, CSF interleukins (Il) IL-6,
IL-8, CSF lactoferrin, tumor necrosis factor alpha (TNF alpha), plasma procalcitonin, CSF
nitrates and nitrites (4-19), in addition to the classical CSF gram staining and culture.
Less developed countries lag far behind in terms of general
public health policies and have therefore higher mortality and morbidity rates. The
reasons for this are multiple; late diagnosis (children being brought too late to
hospitals or primary health centers), insufficient diagnostic tools (poorly equipped or
non-existent laboratories), expensive and unaffordable antibiotics such as the third
generation cephalosporins for example. |
|
| WHY DOES MENINGITIS OCCUR? Meningitis develops when bacterial pathogenic virulence
factors overcome host defense mechanisms. The most common bacteria (Streptococcus
pneumoniae, Heamophilus influenzae, Nisseria meningitidis, Esherichia coli, Streptococcus
agalactiae (Group B Streptococci)) have a certain ability to evade the host natural
defenses by developing evasion mechanisms that help in overcoming each of the barriers
(20). Slide I summarizes these evasion mechanisms.
Meningitis is therefore a result of the colonization of mucosal epithelium >
Bacterial invasion and survival in the intravascular space > Crossing of blood-brain
barrier > Survival in the CSF
|
|
| EPIDEMIOLOGY OF BACTERIAL MENINGITIS Knowledge of the epidemiological features of a disease
is necessary because choices of adequate treatment, which are often presumptive, and
definition of health policies are both based on it. Studies (21-23) have brought certain
global evidences: male children are more affected than female with a male to female ratio
around 1.5:1, there is a seasonal trend with most cases of bacterial meningitis occurring
during fall and winter, however viral cases are more frequent in summer. The commonest
causes of bacterial meningitis are shown in Slide 2.
Before the use of H. influenzae type b (Hib)
vaccination in the western countries, cases of bacterial meningitis were most commonly
caused by H. influenzae (Children aged < 5 years), N. meningitidis, and
S. pneumoniae. Peltola (24) calculated that prior to the use of Hib vaccination there
were 357,000 cases of H. influenzae meningitis worldwide with a mortality rate
around 108,500 in children aged <5 years. The incidence of cases due to H.
influenzae have been decreased by 85 to 90% since the introduction of Hib vaccination;
this has placed N. meningitidis as the leading organism followed by S.
pneumoniae and H. influenzae.
In Africa, S. pneumoniae is the leading cause
followed by N. meningitidis serotype A and H. influenzae. Predisposing
factors in black populations are Sickle cell disease and high sensibility to S. pneumoniae
invasive infections, etc. For all developing countries Hib vaccination is more than needed
as young infants and children loose their natural immunity against H. influenzae
received from their mothers by the age of twenty months (25). |
|
| HOW DOES MENINGITIS PRESENTS AND WHEN SHOULD IT
BE SUSPECTED? Presenting symptoms vary
in children with age at onset, one must distinguish following age groups: the newborn
(from birth to one month of age), infant (2 months to 2 years) and children over two years
of age.
(1) The Newborn and Infant
Signs and symptoms are not specific: the infant may have fever (>38 °C),
refuse to feed or feed poorly, be hypotonic, irritable with unusual cry, sleepy or
inactive, have bulging anterior fontanelle, present with vomiting. With disease
progression seizures may occur, this is the case for 40 % of newborn babies. Premature
babies as well as those born at term may have cold extremities, temperature instability
(hypo or hyperthermia), apnea, respiratory distress, and listlessness as early symptoms.
(2) The older child (>2years)
More than 85% of children with meningitis have the classic triad
of fever, headache and neck stiffness (Slide
3). Papilloedema occurs in only 1% of patients during the acute phase, its
presence should suggest an alternative method of diagnosis. Computed head scan should be
sought before lumbar puncture and the child started on antibiotics to avoid any delay. |
|
1 2 3 next>>
|